In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Frequently asked questions
What is the SPDR S&P Biotech ETF (XBI) expense ratio?
The SPDR S&P Biotech ETF funds expense ratio is 0.35%.
What is SPDR S&P Biotech ETF (XBI) current stock price?
As of the latest data, SPDR S&P Biotech ETF stock price is $156.86, with a previous close of $159.39. SPDR S&P Biotech ETF lost -$2.53 in the last trading session, representing a -1.59% loss.
Does SPDR S&P Biotech ETF (XBI) pay dividends?
Yes. SPDR S&P Biotech ETF pays quarterly dividends with an annualized yield of 0.35% and an estimated annual payout of $0.55 per share.
When is the next ex-dividend date for SPDR S&P Biotech ETF (XBI)?
The next ex-dividend date is scheduled for September 22, 2026.
